Free Shipping on All Orders $75 Or More!

Your Trusted Brand for Over 35 Years

Health Protocols


Abarikwu SO, Otuechere CA, Ekor M, Monwuba K, Osobu D. Rutin Ameliorates Cyclophosphamide-induced Reproductive Toxicity in Male Rats. Toxicology international. May 2012;19(2):207-214.

Albertini E,Martignago S, Bisciglia M, Bonifati M, Ermani M, Pegoraro E,  Angelini C. P-1 Prognostic factors and course of myasthenia gravis. Acta Myol. Oct 2011; 30(2): 161

ALXN. Alexion Pharmaceuticals. A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects with Refractory Generalized Myasthenia Gravis (gMG). In: [Internet]. Bethesda (MD): National Library of Medicine (US). 2014. Accessed 4/2/2014. Available at: NLM Identifier: NCT01997229.

Amadori A, Zamarchi R, De Silvestro G, Forza G, Cavatton G, Danieli GA, . . . Chieco-Bianchi L. Genetic control of the CD4/CD8 T-cell ratio in humans. Nature medicine. Dec 1995;1(12):1279-1283.

Askmark H, Haggard L, Nygren I, Punga AR. Vitamin D deficiency in patients with myasthenia gravis and improvement of fatigue after supplementation of vitamin D3: a pilot study. European journal of neurology : the official journal of the European Federation of Neurological Societies. Dec 2012;19(12):1554-1560.

Bae SC, Jung WJ, Lee EJ, Yu R, Sung MK. Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients. Journal of the American College of Nutrition. Feb 2009;28(1):56-62.

Bains I, Yates AJ, Callard RE. Heterogeneity in thymic emigrants: implications for thymectomy and immunosenescence. PloS one. 2013;8(2):e49554.

Bashuk RG, Krendel DA. Myasthenia gravis presenting as weakness after magnesium administration. Muscle & nerve. Aug 1990;13(8):708-712.

Basta IZ, Pekmezovic TD, Peric SZ, Kisic-Tepavcevic DB, Rakocevic-Stojanovic VM, Stevic ZD, Lavrnic DV. Assessment of health-related quality of life in patients with myasthenia gravis in Belgrade (Serbia). Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. Dec 2012;33(6):1375-1381.

Beisswanger E, DeLuca DS, Blasczyk R, Hahn U. An ontology for major histocompatibility complex (MHC) alleles and molecules. AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium. 2007:41-45.

Berrih-Aknin S, Le Panse R. [Myasthenia gravis and autoantibodies: Pathophysiology of the different subtypes.]. La Revue de medecine interne / fondee ... par la Societe nationale francaise de medecine interne. Oct 21 2013.

Berrih-Aknin S, Le Panse R. Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms. J Autoimmun. 2014. [Epub ahead of print]

Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer research. Jan 15 2006;66(2):1234-1240.

Boots AW, Drent M, de Boer VC, Bast A, Haenen GR. Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis. Clin Nutr. Aug 2011;30(4):506-512.

Bryan J, Borthakur G. Role of rituximab in first-line treatment of chronic lymphocytic leukemia. Therapeutics and clinical risk management. 2010;7:1-11.

Catanzarite VA, McHargue AM, Sandberg EC, Dyson DC. Respiratory arrest during therapy for premature labor in a patient with myasthenia gravis. Obstetrics and gynecology. Dec 1984;64(6):819-822.

Cavalcante P, Maggi L, Colleoni L, Caldara R, Motta T, Giardina C, . . . Mantegazza R. Inflammation and epstein-barr virus infection are common features of myasthenia gravis thymus: possible roles in pathogenesis. Autoimmune diseases. 2011;2011:213092.

Chen T, Guo ZP, Wang L, Qin S, Cao N, Li MM, . . . Wang TT. Paeoniflorin suppresses vascular damage and the expression of E-selectin and ICAM-1 in a mouse model of cutaneous Arthus reaction. Experimental dermatology. Jul 2013;22(7):453-457.

Cohen BA, London RS, Goldstein PJ. Myasthenia gravis and preeclampsia. Obstetrics and gynecology. Jul 1976;48(1 Suppl):35S-37S.

Collongues N, Casez O, Lacour A, Tranchant C, Vermersch P, de Seze J, Lebrun C. Rituximab in refractory and non-refractory myasthenia: a retrospective multicenter study. Muscle & nerve. Nov 2012;46(5):687-691.

Corse A, Mankodi A. ePocrates online: Diseases page. Myasthenia Gravis. Available at: Last updated 1/2/2014. Accessed 4/3/2014.

Cutter G and Wolfe G. University of Alabama at Birmingham. A Multi-Center, Single-Blind, Randomized Study Comparing Thymectomy to No Thymectomy in Non-Thymomatous Myasthenia Gravis (MG) Patients Receiving Prednisone. In: [Internet]. Bethesda (MD): National Library of Medicine (US). 2013. Accessed 4/2/2014. Available at: NLM Identifier: NCT00294658.

De Feo LG, Schottlender J, Martelli NA, Molfino NA. Use of intravenous pulsed cyclophosphamide in severe, generalized myasthenia gravis. Muscle & nerve. Jul 2002;26(1):31-36.

Diaz A, Black E, Dunning J. Is thymectomy in non-thymomatous myasthenia gravis of any benefit? Interactive cardiovascular and thoracic surgery. Dec 18 2013.

Diaz-Manera J, Martinez-Hernandez E, Querol L, Klooster R, Rojas-Garcia R, Suarez-Calvet X, . . . Illa I. Long-lasting treatment effect of rituximab in MuSK myasthenia. Neurology. Jan 17 2012;78(3):189-193.

Dongren Y, Tao L, Fengsheng H. Electroneurophysiological studies in rats of acute dimethoate poisoning. Toxicology letters. Jun 30 1999;107(1-3):249-254.

Du JH, Dong BD. [Comparative study on clinical efficacy of using methotrexate singly or combined with total glucosides of Paeony in treating rheumatoid arthritis]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban. Jun 2005;25(6):540-542.

Evoli A, Tonali PA, Padua L, Monaco ML, Scuderi F, Batocchi AP, . . . Bartoccioni E. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain : a journal of neurology. Oct 2003;126(Pt 10):2304-2311.

Fee DB, Kasarskis EJ. Myasthenia gravis associated with etanercept therapy. Muscle & nerve. Jun 2009;39(6):866-870.

Feldmann M, Maini RN. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annual review of immunology. 2001;19:163-196.

Ferrero S, Pretta S, Nicoletti A, Petrera P, Ragni N. Myasthenia gravis: management issues during pregnancy. European journal of obstetrics, gynecology, and reproductive biology. Aug 1 2005;121(2):129-138.

Fregonezi GA, Resqueti VR, Guell R, Pradas J, Casan P. Effects of 8-week, interval-based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest. Sep 2005;128(3):1524-1530.

Galarraga B, Ho M, Youssef HM, Hill A, McMahon H, Hall C, . . . Belch JJ. Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis. Rheumatology (Oxford). May 2008;47(5):665-669.

Genentech. Rituxan® (rituximab). Highlights of Prescribing Information. Available at: Last udpated 9/2013. Accessed 4/3/2014.

Gerli R, Paganelli R, Cossarizza A, et al. Long-term immunologic effects of thymectomy in patients with myasthenia gravis. J Allergy Clin Immunol. 1999;103(5 Pt 1):865-72.

Grohar-Murray ME, Becker A, Reilly S, Ricci M. Self-care actions to manage fatigue among myasthenia gravis patients. The Journal of neuroscience nursing: journal of the American Association of Neuroscience Nurses. Jun 1998;30(3):191-199.

GSK. GlaxoSmithKline. A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG). In: [Internet]. Bethesda (MD): National Library of Medicine (US). 2014. Accessed 4/2/2014. Available at: NLM Identifier: NCT01480596.

Hafer-Macko CE. Baltimore VA Medical Center; University of Mayrland. Multi-modal Exercise Program for Chronic Stable Myasthenia Gravis. In: [Internet]. Bethesda (MD): National Library of Medicine (US). 2013. Accessed 4/2/2014. Available at: NLM Identifier: NCT01047761.

Haraoui B, Bykerk V. Etanercept in the treatment of rheumatoid arthritis. Therapeutics and clinical risk management. Mar 2007;3(1):99-105.

Harrison AM, Thalji NM, Greenberg AJ, Tapia CJ, Windebank AJ. Rituximab for non-Hodgkin's lymphoma: a story of rapid success in translation. Clinical and translational science. Feb 2014;7(1):82-86.

He DY, Dai SM. Anti-inflammatory and immunomodulatory effects of paeonia lactiflora pall., a traditional chinese herbal medicine. Frontiers in pharmacology. 2011;2:10.

He F, Xu H, Qin F, Xu L, Huang J, He X. Intermediate myasthenia syndrome following acute organophosphates poisoning--an analysis of 21 cases. Human & experimental toxicology. Jan 1998;17(1):40-45.

Heinz SA, Henson DA, Nieman DC, Austin MD, Jin F. A 12-week supplementation with quercetin does not affect natural killer cell activity, granulocyte oxidative burst activity or granulocyte phagocytosis in female human subjects. The British journal of nutrition. Sep 2010;104(6):849-857.

Hersey P, Bradley M, Hasic E, Haran G, Edwards A, McCarthy WH. Immunological effects of solarium exposure. Lancet. Mar 12 1983;1(8324):545-548.

Hersey P, Haran G, Hasic E, Edwards A. Alteration of T cell subsets and induction of suppressor T cell activity in normal subjects after exposure to sunlight. J Immunol. Jul 1983;131(1):171-174.

Hewison M. Vitamin D and immune function: an overview. The Proceedings of the Nutrition Society. Feb 2012;71(1):50-61.

Ho PC, Tang GW, Lawton JW. Lymphocyte subsets in patients with oestrogen deficiency. Journal of reproductive immunology. May 1991;20(1):85-91.

Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nature medicine. Mar 2001;7(3):365-368.

Howard JF, Jr., Barohn RJ, Cutter GR, Freimer M, Juel VC, Mozaffar T, . . . Kissel JT. A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis. Muscle & nerve. Jul 2013;48(1):76-84.

Howard JF. MGFA: Myasthenia Gravis Foundation of America, Inc. Clinical Overview of MG. Available at: Copyright © 2006. Accessed 4/3/2014.

Huang D, Pirskanen R, Matell G, Lefvert AK. Tumour necrosis factor-α polymorphism and secretion in myasthenia gravis. Journal of Neuroimmunology. 1999;94(1–2):165-171.

Jagetia GC, Aggarwal BB. "Spicing up" of the immune system by curcumin. Journal of clinical immunology. Jan 2007;27(1):19-35.

Jasmin L. MedlinePlus web page. Tensilon Test. Available at: Last updated 2/26/2014. Accessed 4/3/2014.

Jayam Trouth A, Dabi A, Solieman N, Kurukumbi M, Kalyanam J. Myasthenia gravis: a review. Autoimmune diseases. 2012;2012:874680.

Jeyaratnam J. Acute pesticide poisoning: a major global health problem. World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales. 1990;43(3):139-144.

Jimenez JJ, Huang HS, Yunis AA. Treatment with ImuVert/N-acetylcysteine protects rats from cyclophosphamide/cytarabine-induced alopecia. Cancer investigation. 1992;10(4):271-276.

Johnson LA, Malayappan B, Tretyakova N, Campbell C, MacMillan ML, Wagner JE, Jacobson PA. Formation of cyclophosphamide specific DNA adducts in hematological diseases. Pediatric blood & cancer. May 2012;58(5):708-714.

Jonklass J, Helfand M. Office of Women’s Health website. Publications page. Thyroid Disease Fact Sheet. Available at: Last updated 7/16/2012. Accessed 4/3/2014.

Juel VC. Myasthenia gravis: management of myasthenic crisis and perioperative care. Seminars in neurology. Mar 2004;24(1):75-81.

Jurenka JS. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Alternative medicine review : a journal of clinical therapeutic. Jun 2009;14(2):141-153.

Kearsey C, Fernando P, D'Costa D, Ferdinand P. The use of the ice pack test in myasthenia gravis. JRSM short reports. 2010;1(1):14.

Kim HR, Rajaiah R, Wu QL, Satpute SR, Tan MT, Simon JE, . . . Moudgil KD. Green tea protects rats against autoimmune arthritis by modulating disease-related immune events. The Journal of nutrition. Nov 2008;138(11):2111-2116.

Kleemann R, Verschuren L, Morrison M, Zadelaar S, van Erk MJ, Wielinga PY, Kooistra T. Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models. Atherosclerosis. Sep 2011;218(1):44-52.

Kley RA, Tarnopolsky MA, Vorgerd M. Creatine for treating muscle disorders. The Cochrane database of systematic reviews. 2013;6:CD004760.

Kodama S, Davis M, Faustman DL. The therapeutic potential of tumor necrosis factor for autoimmune disease: a mechanistically based hypothesis. Cellular and molecular life sciences : CMLS. Aug 2005;62(16):1850-1862.

Kos MI, Hoshino AC, Asmus CI, Mendonca R, Meyer A. [Peripheral and central auditory effects of pesticide exposure: a systematic review]. Cadernos de saude publica. Aug 2013;29(8):1491-1506.

Kusner LL, Kaminski HJ. The role of complement in experimental autoimmune myasthenia gravis. Annals of the New York Academy of Sciences. Dec 2012;1274:127-132.

Lebrun C, Bourg V, Tieulie N, Thomas P. Successful treatment of refractory generalized myasthenia gravis with rituximab. European journal of neurology : the official journal of the European Federation of Neurological Societies. Feb 2009;16(2):246-250.

Leker RR, Karni A, Abramsky O. Exacerbation of myasthenia gravis during the menstrual period. Journal of the neurological sciences. 1998;156(1):107-111.

Li Y, Xiao B, Xiao L, Zhang N, Yang H. Myasthenia gravis accompanied by premature ovarian failure and aggravation by estrogen. Internal medicine (Tokyo, Japan). 2010;49(6):611-613.

Lin J, Xiao L, Ouyang, et al. Total glucosides of paeony inhibits Th1/Th17 cells via decreasing dendritic cells activation in rheumatoid arthritis. Cell Immunol. 2012 Dec;280(2):156-63.

Lucia A, Mate-Munoz JL, Perez M, Foster C, Gutierrez-Rivas E, Arenas J. Double trouble (McArdle's disease and myasthenia gravis): how can exercise help? Muscle & nerve. Jan 2007;35(1):125-128.

Maggini S, Wintergerst ES, Beveridge S, Hornig DH. Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses. The British journal of nutrition. Oct 2007;98 Suppl 1:S29-35.

Mahmoud MF, Hassan NA, El Bassossy HM, Fahmy A. Quercetin protects against diabetes-induced exaggerated vasoconstriction in rats: effect on low grade inflammation. PloS one. 2013;8(5):e63784.

Maroon JC, Bost JW, Maroon A. Natural anti-inflammatory agents for pain relief. Surgical neurology international. 2010;1:80.

Martinez De Lapiscina EH, Aguirre ME, Blanco TA, Pascual IJ. Myasthenia gravis: sleep quality, quality of life, and disease severity. Muscle & nerve. Aug 2012;46(2):174-180.

Matsumoto Y, Kanamori A, Nakamura M, Takahashi T, Nakashima I, Negi A. Sera from patients with seropositive neuromyelitis optica spectral disorders caused the degeneration of rodent optic nerve. Experimental eye research. Feb 2014;119:61-69.

Mayo Clinic. Patient Care & Health Info page. Diseases and Conditions. Myasthenia Gravis. Complications. Available at: 4/23/2013. Accessed 4/2/2014.

MedlinePlus. Drugs & Supplements page. Cyclophosphamide. Available at: Last updated 9/15/2011. Accessed 5/20/2014.

MedlinePlus. Drugs & Supplements page. Vitamin D. Available at: Last updated 3/12/2014. Accessed 4/2/2014.

Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet neurology. May 2009;8(5):475-490.

Meriggioli MN, Sanders DB. Muscle autoantibodies in myasthenia gravis: beyond diagnosis? Expert review of clinical immunology. Jul 2012a;8(5):427-438.

Meriggioli MN. University of Illinois at Chicago. A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Symptomatic Autoimmune Generalized Myasthenia Gravis. In: [Internet]. Bethesda (MD): National Library of Medicine (US). 2012b. Accessed 4/2/2014. Available at: NLM Identifier: NCT01555580.

MGFA. Myasthenia Gravis Foundation of America, Inc. Important Statement. Available at: Accessed 4/2/2014.

MGFA. Myasthenia Gravis Foundation of America, Inc. Nutrition and Myasthenia Gravis. A helpful guide for patients and their caregivers. Available at: Copyright © 2009. Accessed 4/2/2014.

MGFA. Myasthenia Gravis Foundation of America, Inc. Plasmapheresis. Common questions patients ask about plasmapheresis. Available at: Copyright © 2010a. Accessed 4/2/2014.

MGFA. Myasthenia Gravis Foundation of America, Inc. Treatment for MG. Available at: Copyright © 2010b. Accessed 4/2/2014.

MGFI. Myasthenia Gravis Foundation of Illinois. Exercise. Available at: Accessed 5/19/2014.

Mihatsch MJ, Kyo M, Morozumi K, Yamaguchi Y, Nickeleit V, Ryffel B. The side-effects of ciclosporine-A and tacrolimus. Clinical nephrology. Jun 1998;49(6):356-363.

Nguyen TU, Koo J. Etanercept in the treatment of plaque psoriasis. Clinical, cosmetic and investigational dermatology. 2009;2:77-84.

NIAID. National Institute of Allergy and Infectious Diseases. National Institutes of Health (NIH) online. Health & Research Topics page. Immune System. Complement System. Available at: Last updated 10/2/2008. Accessed 4/2/2014.

NIAID. National Institutes of Allergy and Infectious Diseases. National Institutes of Health (NIH) online. Health & Research Topics page. Immune System. Immune Cells. Available at: Last updated 1/17/2014. Accessed 4/2/2014.

NINDS. National Institute of Neurological Disorders and Stroke. National Institutes of Health (NIH) online. Myasthenia Gravis Fact Sheet. Available at: Last updated 12/4/2012. Accessed 4/2/2014.

NINDS. National Institute of Neurological Disorders and Stroke. National Institutes of Health (NIH) online. NINDS Neuromyelitis Optica Information Page. Available at: Last updated 2/14/2014. Accessed 4/2/2014.

Niu GH, Sun X, Zhang CM. [Effect of compound astragalus recipe on lymphocyte subset, immunoglobulin and complements in patients with myasthenia gravia]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban. Apr 2009;29(4):305-308.

O'Brien MA, Jackson MW. Vitamin D and the immune system: beyond rickets. Veterinary journal (London, England: 1997). Oct 2012;194(1):27-33.

O'Donnell S, Cranney A, Horsley T, Weiler HA, Atkinson SA, Hanley DA, . . . Yazdi F. Efficacy of food fortification on serum 25-hydroxyvitamin D concentrations: systematic review. The American journal of clinical nutrition. Dec 2008;88(6):1528-1534.

Olivier B. Assistance Publique – Hôpitaux de Paris. FORCE: Rituximab (CD 20+-B Cell-depleting Monoclonal Antibody) for the Treatment of Refractory Inflammatory Myopathies With Specific Antibodies and Refractory Myasthenia Gravis. In: [Internet]. Paris, France. 2012. Accessed 4/2/2014. Available at: NLM Identifier: NCT00774462.

Orhan IE. Nature: a substantial source of auspicious substances with acetylcholinesterase inhibitory action. Current neuropharmacology. Jul 2013;11(4):379-387.

Park Y, Lee A, Shim SC, Lee JH, Choe JY, Ahn H, . . . Bae SC. Effect of n-3 polyunsaturated fatty acid supplementation in patients with rheumatoid arthritis: a 16-week randomized, double-blind, placebo-controlled, parallel-design multicenter study in Korea. The Journal of nutritional biochemistry. Jul 2013;24(7):1367-1372.

Peairs A, Dai R, Gan L, Shimp S, Rylander MN, Li L, Reilly CM. Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL/lpr mouse mesangial cells. Cellular & molecular immunology. Mar 2010;7(2):123-132.

Pender MP. CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis. Autoimmune diseases. 2012;2012:189096.

Qi H, Li J, Allman W, Saini SS, Tuzun E, Wu X, . . . Christadoss P. Genetic deficiency of estrogen receptor alpha fails to influence experimental autoimmune myasthenia gravis pathogenesis. Journal of neuroimmunology. May 2011;234(1-2):165-167.

Ragheb S, Lisak RP. B-cell-activating factor and autoimmune myasthenia gravis. Autoimmune diseases. 2011;2011:939520.

Rassler B, Hallebach G, Kalischewski P, Baumann I, Schauer J, Spengler CM. The effect of respiratory muscle endurance training in patients with myasthenia gravis. Neuromuscular disorders : NMD. May 2007;17(5):385-391.

Rehan KM. An Overview of the Thymus: The Gland that Protects You Long after It’s Gone. endocrineweb online. Available at: Last updated 11/16/2012. Accessed 5/27/2014.

Ren S, Zhang H, Mu Y, Sun M, Liu P. Pharmacological effects of Astragaloside IV: a literature review. Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan / sponsored by All-China Association of Traditional Chinese Medicine, Academy of Traditional Chinese Medicine. Jun 2013;33(3):413-416.

Rowin J, Meriggioli MN, Tuzun E, Leurgans S, Christadoss P. Etanercept treatment in corticosteroid-dependent myasthenia gravis. Neurology. Dec 28 2004;63(12):2390-2392.

Rowin J, Thiruppathi M, Arhebamen E, Sheng J, Prabhakar BS, Meriggioli MN. Granulocyte macrophage colony-stimulating factor treatment of a patient in myasthenic crisis: effects on regulatory T cells. Muscle & nerve. Sep 2012;46(3):449-453.

Ruckert JC, Swierzy M, Ismail M. Comparison of robotic and nonrobotic thoracoscopic thymectomy: a cohort study. The Journal of thoracic and cardiovascular surgery. Mar 2011;141(3):673-677.

Rup T. University of Vermont. Phase 1-2 Pilot Study of Rituximab (Rituxan) in Refractory Myasthenia Gravis. In: [Internet]. Bethesda (MD): National Library of Medicine (US). 2013. Accessed 4/2/2014. Available at: NLM Identifier: NCT00619671.

RxList. DRUGS A-Z page. Cytoxan. Available at: Copyright © 2014. Accessed 6/2/2014.

Sakuma S, Kato Y, Nishigaki F, Sasakawa T, Magari K, Miyata S, . . . Goto T. FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells. British journal of pharmacology. Aug 2000;130(7):1655-1663.

Sanders DB, Evoli A. Immunosuppressive therapies in myasthenia gravis. Autoimmunity. Aug 2010;43(5-6):428-435.

Sanders DB, Hart IK, Mantegazza R, Shukla SS, Siddiqi ZA, De Baets MH, . . . Richman DP. An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis. Neurology. Aug 5 2008;71(6):400-406.

Sandoval M, Charbonnet RM, Okuhama NN, Roberts J, Krenova Z, Trentacosti AM, Miller MJ. Cat's claw inhibits TNFalpha production and scavenges free radicals: role in cytoprotection. Free radical biology & medicine. Jul 1 2000;29(1):71-78.

Sathasivam S. Current and emerging treatments for the management of myasthenia gravis. Therapeutics and clinical risk management. 2011;7:313-323.

Sauce D, Larsen M, Fastenackels S, et al. Evidence of premature immune aging in patients thymectomized during early childhood. The Journal of Clinical Investigation. 2009;119(10):3070-3078.

Schuna AA. Rituximab for the treatment of rheumatoid arthritis. Pharmacotherapy. Dec 2007;27(12):1702-1710.

Selvan VA. Single-fiber EMG: A review. Annals of Indian Academy of Neurology. Jan 2011;14(1):64-67.

Shi X, Zhou W, Huang H, Zhu H, Zhou P, Zhu H, Ju D. Inhibition of the inflammatory cytokine tumor necrosis factor-alpha with etanercept provides protection against lethal H1N1 influenza infection in mice. Critical care (London, England). Dec 27 2013;17(6):R301.

Sieb JP. Myasthenia gravis: an update for the clinician. Clinical and experimental immunology. Mar 2014;175(3):408-418.

Spillane J, Hayward M, Hirsch NP, Taylor C, Kullmann DM, Howard RS. Thymectomy: role in the treatment of myasthenia gravis. Journal of neurology. Jul 2013;260(7):1798-1801.

Stout JR, Eckerson JM, May E, Coulter C, Bradley-Popovich GE. Effects of resistance exercise and creatine supplementation on myasthenia gravis: a case study. Medicine and science in sports and exercise. Jun 2001;33(6):869-872.

Suzuki S, Utsugisawa K, Suzuki N. Overlooked non-motor symptoms in myasthenia gravis. Journal of neurology, neurosurgery, and psychiatry. Sep 2013;84(9):989-994.

Takahama Y. Journey through the thymus: stromal guides for T-cell development and selection. Nature reviews. Immunology. Feb 2006;6(2):127-135.

Tanhehco JL. Single-fiber electromyography. Physical medicine and rehabilitation clinics of North America. May 2003;14(2):207-229.

Tavee J, Bruce B, Ferri F. Myasthenia gravis. First Consult. Available at: Last updated 9/2/2010. Accessed 4/2/2014.

Thangarajh M, Masterman T, Helgeland L, Rot U, Jonsson MV, Eide GE, . . . Jonsson R. The thymus is a source of B-cell-survival factors-APRIL and BAFF-in myasthenia gravis. Journal of neuroimmunology. Sep 2006;178(1-2):161-166.

Thanvi BR, Lo TCN. Update on myasthenia gravis. Postgrad Med J. 2004;80:690-700.

Thiruppathi M, Rowin J, Ganesh B, Sheng JR, Prabhakar BS, Meriggioli MN. Impaired regulatory function in circulating CD4(+)CD25(high)CD127(low/-) T cells in patients with myasthenia gravis. Clin Immunol. Dec 2012;145(3):209-223.

Thiruppathi M, Rowin J, Li Jiang Q, Sheng JR, Prabhakar BS, Meriggioli MN. Functional defect in regulatory T cells in myasthenia gravis. Annals of the New York Academy of Sciences. Dec 2012;1274:68-76.

Thoms KM, Kuschal C, Oetjen E, Mori T, Kobayashi N, Laspe P, . . . Emmert S. Cyclosporin A, but not everolimus, inhibits DNA repair mediated by calcineurin: implications for tumorigenesis under immunosuppression. Experimental dermatology. Mar 2011;20(3):232-236.

Tu LH, Huang DR, Zhang RQ, Shen Q, Yu YY, Hong YF, Li GH. Regulatory action of Astragalus saponins and buzhong yiqi compound on synthesis of nicotinic acetylcholine receptor antibody in vitro for myasthenia gravis. Chinese medical journal. Apr 1994;107(4):300-303.

UIC. University of Illinois at Chicago. Drug Information Group. Frequently Asked Questions page. What drugs should be avoided in myasthenia gravis? Available at: Copyright © 2007. Accessed 4/3/2014.

Vincent A, Leite MI, Farrugia ME, Jacob S, Viegas S, Shiraishi H, . . . Willcox N. Myasthenia gravis seronegative for acetylcholine receptor antibodies. Annals of the New York Academy of Sciences. 2008;1132:84-92.

Wang J, Ren Z, Xu Y, Xiao S, Meydani SN, Wu D. Epigallocatechin-3-gallate ameliorates experimental autoimmune encephalomyelitis by altering balance among CD4+ T-cell subsets. The American journal of pathology. Jan 2012;180(1):221-234.

Wang SL, Wang JP, Bian H. [Clinical observation on total glucosides of paeony combined with sulfasalazine in treatment of ankylosing spondylitis]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban. Mar 2007;27(3):217-219.

Wang Y, Xing HY. [Clinical observation on effect of total glucosides of paeony combined with methotrexate on rheumatoid arthritis]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban. Sep 2007;27(9):839-840.

Wang YN, Zhang Y, Wang Y, Zhu DX, Xu LQ, Fang H, Wu W. The beneficial effect of total glucosides of paeony on psoriatic arthritis links to circulating tregs and Th1 cell function. Phytotherapy research: PTR. Mar 2014;28(3):372-381.

Weiner P, Gross D, Meiner Z, Ganem R, Weiner M, Zamir D, Rabner M. Respiratory muscle training in patients with moderate to severe myasthenia gravis. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. Aug 1998;25(3):236-241.

Weiss G, Meyer F, Matthies B, Pross M, Koenig W, Lippert H. Immunomodulation by perioperative administration of n-3 fatty acids. The British journal of nutrition. Jan 2002;87 Suppl 1:S89-94.

Winters JL. Plasma exchange: concepts, mechanisms, and an overview of the American Society for Apheresis guidelines. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2012;2012:7-12.

Wong SH, Nitz JC, Williams K, Brauer SG. Effects of balance strategy training in myasthenia gravis: A case study series. Muscle & nerve. Aug 22 2013.

Wong SH, Nitz JC, Williams K, Brauer SG. Effects of balance strategy training in myasthenia gravis: A case study series. Muscle & nerve. May 2014;49(5):654-660.

Wright SA, O'Prey FM, McHenry MT, Leahey WJ, Devine AB, Duffy EM, . . . McVeigh GE. A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus. Annals of the rheumatic diseases. Jun 2008;67(6):841-848.

Wu D, Wang J, Pae M, Meydani SN. Green tea EGCG, T cells, and T cell-mediated autoimmune diseases. Molecular aspects of medicine. Feb 2012;33(1):107-118.

Yang CC, Deng JF. Intermediate syndrome following organophosphate insecticide poisoning. Journal of the Chinese Medical Association : JCMA. Nov 2007;70(11):467-472.

Yang D, Niu Y, He F. Functional changes of nicotinic acetylcholine receptor in muscle and lymphocyte of myasthenic rats following acute dimethoate poisoning. Toxicology. Jul 1 2005;211(1-2):149-155.

Yiannakopoulou E. Targeting oxidative stress response by green tea polyphenols: clinical implications. Free radical research. Sep 2013;47(9):667-671.

Zagoriti Z, Kambouris ME, Patrinos GP, Tzartos SJ, Poulas K. Recent advances in genetic predisposition of myasthenia gravis. BioMed research international. 2013;2013:404053.

Zhang B, Tzartos JS, Belimezi M, Ragheb S, Bealmear B, Lewis RA, . . . Mei L. Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis. Archives of neurology. Apr 2012;69(4):445-451.

Zhang HF, Xiao WG, Hou P. [Clinical study of total glucosides of paeony in patients with systemic lupus erythematosus]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban. Apr 2011;31(4):476-479.

Zhang Z, Wang X, Chen Q, Shu L, Wang J, Shan G. [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial]. Zhonghua yi xue za zhi. Jul 25 2002;82(14):941-944.

Zhou Z, Lin J, Huo R, Huang W, Zhang J, Wang L, . . . Li N. Total glucosides of paeony attenuated functional maturation of dendritic cells via blocking TLR4/5 signaling in vivo. International immunopharmacology. Nov 2012;14(3):275-282.

Zofkova I, Kancheva RL. The effect of 1,25(OH)2 vitamin D3 on CD4+/CD8+ subsets of T lymphocytes in postmenopausal women. Life sciences. 1997;61(2):147-152.